Im Rahmen der externen Qualitätssicherung versuchen wir mit jedem möglichen Parameter an externen Qualitätssicherungs-Programmen teilzunehmen.
Die Zertifikate über die erfolgreiche Teilnahme sind unter einer fortlaufenden Nummer als PDF-Dokumente in der unten aufgeführten Tabelle hinterlegt. Durch "Anklicken" der Nummer können die ausgewählten Zertifikate aufgerufen werden.
|
|
| | gültig bis einschl. |
| RILI-BÄK-pflichtige Parameter | | | Apr | Mär | Feb | Jan | Dez | Nov | Okt | Sep | Aug | Jul | Jun | Mai |
|---|
| Stand 30.05.2022 | 2024 | 2024 | 2024 | 2024 | 2023 | 2023 | 2023 | 2023 | 2023 | 2023 | 2023 | 2023 |
|---|
| Hämatokrit | Blut | HA/612 | | | | | | | | | | | | |
| Hämoglobin | Blut | HA/612 | | | | | | | | | | | | |
| Hämoglobin (qualitativ) | Urin | KU | | | | | | | | | | | | |
| Hämoglobin im Stuhl, immunologisch (IFOBT) | Stuhl | 131/FD | | | | | | | | | | | | |
| Haptoglobin | Serum | IG | | | | | | | | | | | | |
| Harnsäure | Serum | 100/KS | | | | | | | | | | | | |
| Harnsäure i.U. | Urin | -- | | | | | | | | | | | | |
| Harnstoff | Serum | 100/KS | | | | | | | | | | | | |
| Harnstoff i.U. | Urin | KU | | | | | | | | | | | | |
| HbA1c | Blut | 145 | | | | | | | | | | | | |
| HCG | Serum | SD | | | | | | | | | | | | |
| HCG (frei) | Serum | SD | | | | | | | | | | | | |
| HCV-RNA | PCR | 362 | | | | | | | | | | | | |
| HDL | Serum | LP | | | | | | | | | | | | |
| Helicobacter ELISA IgA | Serum | 334 | | | | | | | | | | | | |
| Helicobacter ELISA IgG | Serum | 334 | | | | | | | | | | | | |
| Helicobacter Immunoblot IgA | Serum | inaktiv | | | | | | | | | | | | |
| Helicobacter Immunoblot IgG | Serum | inaktiv | | | | | | | | | | | | |
| Hepatitis A Anti-HAV-IgG (bzw.Anti HAV gesamt) | Serum | 343 | | | | | | | | | | | | |
| Hepatitis A Anti-HAV-IgM | Serum | 343 | | | | | | | | | | | | |
| Hepatitis B Anti-HBc | Serum | HBVimm2 | | | | | | | | | | | | |
| Hepatitis B Anti-HBc-IgM | Serum | HBVimm2 | | | | | | | | | | | | |
| Hepatitis B Anti-HBe | Serum | HBVimm2 | | | | | | | | | | | | |
| Hepatitis B Anti-HBs | Serum | HBVimm2 | | | | | | | | | | | | |
| Hepatitis B HBeAG | Serum | HBVimm2 | | | | | | | | | | | | |
| Hepatitis B HBsAG | Serum | HBVimm2 | | | | | | | | | | | | |
| Hepatitis C Anti-HCV | Serum | HCVImm | | | | | | | | | | | | |
| Hepatitis E IgG | Serum | 348 | | | | | | | | | | | | |
| Hepatitis E IgM | Serum | 348 | | | | | | | | | | | | |
| HFE (gen.) | Blut | MG1 | | | | | | | | | | | | |
| HIV | Serum | HIVImm | | | | | | | | | | | | |
| HLA-B 27 (gen.) | Blut | MG2 | | | | | | | | | | | | |
| Holotranscobalmin (HTC) | Serum | 290 | | | | | | | | | | | | |
| Homocystein | Plasma | LP | | | | | | | | | | | | |
| HPV- Genom | PCR | 373 | | | | | | | | | | | | |
| HSV 1/2 IgG EIA | Serum | HerpVimm | | | | | | | | | | | | |
| HSV 1/2 IgM EIA | Serum | HerpVimm | | | | | | | | | | | | |
| HSV-AK | Liquor | 463 | | | | | | | | | | | | |
| HTT (gen.) | Blut | 784 | 1381 | | | | | | | | | | | |
| humane Metapneumoviren (RNA) qual. | PCR | 431 | | | | | | | | | | | | |
| humane Rhinoviren (RNA) qual. | PCR | 431 | | | | | | | | | | | | |
|